AI assistant
SPACETALK LTD — Share Issue/Capital Change 2025
Jul 21, 2025
65842_rns_2025-07-21_436c80b1-a9aa-4ff0-aa2e-645b771a1a77.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
SPACETALK LTD
Announcement Type
New announcement
Date of this announcement
Tuesday July 22, 2025
The +securities to be quoted are:
+Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer
Total number of +securities to be quoted
| ASX +security | Number of +securities to | ||
|---|---|---|---|
| code | Security description | be quoted | Issue date |
| SPA | ORDINARY FULLY PAID | 200,000 | 18/07/2025 |
Refer to next page for full details of the announcement
Appendix 2A - Application for quotation of securities
1 / 7
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of entity
SPACETALK LTD
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type
ACN
Registration number
091351530
1.3 ASX issuer code
SPA
1.4 The announcement is
New announcement
1.5 Date of this announcement
22/7/2025
Appendix 2A - Application for quotation of securities
2 / 7
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 2 - Type of Issue
2.1 The +securities to be quoted are:
+Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer
2.2 The +class of +securities to be quoted is:
Additional +securities in a class that is already quoted on ASX ("existing class")
Appendix 2A - Application for quotation of securities
3 / 7
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B
Additional +securities to be quoted in an existing class issued under an +employee incentive scheme FROM (Existing Class) ASX +security code and description SPAAR : INCENTIVE RIGHT
TO (Existing Class) ASX +security code and description
SPA : ORDINARY FULLY PAID
Please state the number of +securities issued under the +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer 200,000
Please provide details of a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms
A summary of the terms of the Equity Incentive Plan is provided in Annexure B of 2023 Annual General Meeting Notice of Meeting, which is available on the ASX announcement platform at https://announcements.asx.com.au/asxpdf/20231013/p df/05w11gx11ckbr6.pdf
Are any of these +securities being issued to +key management personnel (KMP) or an +associate No
Issue date
18/7/2025
Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?
Yes
Appendix 2A - Application for quotation of securities
4 / 7
Appendix 2A - Application for quotation of securities
Issue details
==> picture [21 x 22] intentionally omitted <==
Number of +securities to be quoted
200,000
Are the +securities being issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
The fully paid ordinary shares were issued for nil consideration upon the exercise of vested performance rights. The rights were issued for nil consideration under the Equity Incentive Plan.
Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted
33,000.000000
Any other information the entity wishes to provide about the +securities to be quoted
The value of consideration is based the closing trade price for Spacetalk shares on the day the performance right were exercised.
Appendix 2A - Application for quotation of securities
5 / 7
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)
+securities subject of this application) |
|
|---|---|
| Total number of | |
| ASX +security code and description | +securities on issue |
| SPA : ORDINARY FULLY PAID | 73,112,682 |
| SPAO : OPTION EXPIRING 22-SEP-2025 | 19,165,688 |
| 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) | |
| Total number of | |
| ASX +security code and description | +securities on issue |
| SPAAAA : WARRANTS | 2 |
| SPAAR : INCENTIVE RIGHT | 1,233,960 |
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
Appendix 2A - Application for quotation of securities
6 / 7
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 5 - Other Listing Rule requirements
5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? Yes
5.1a Select the number of the applicable exception in Listing Rule 7.2
13
Appendix 2A - Application for quotation of securities
7 / 7